Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative Effects of Olanzapine and Risperidone on Glucose and Lipid Metabolism
NCT00287820Phase 4Completed
- Sponsor
- Nathan S. Kline Institute for Psychiatric Research
- Start
- Feb 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of olanzapine in schizophrenia and schizoaffective disorder (2 arms), sponsored by Nathan S. Kline Institute for Psychiatric Research. Primary endpoints: Serum glucose levels at 5 months, Glycosylated hemoglobin at 5 months and 4 more. Started Feb 2004; status: completed.
02
Drugs
olanzapine
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00287820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00287820.